What do you think of Langsam's report on Biotech Daily. You would have to agree that it is not very professional, particularly the way that he keeps mixing up his stocks and which ones closed up and which ones closed down.
What did you make of his comments towards Solagran at the end of his report on Friday? It struck me as odd but I would like to hear from someone without rose coloured glasses.
Cheers Charles
SLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held